No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of candidate molecules, researchers at Paris Brain Institute, coordinated by Bernard Zalc, have developed a new model of the disease described in Brain.
Leave A Comment